<DOC>
	<DOCNO>NCT02715375</DOCNO>
	<brief_summary>This pivotal , 12-month , randomize , sham control , parallel group , multicenter , double blind study allocation ratio 1:1 . The study population child age 6 17 year , mild moderate persistent asthma . The purpose study determine whether CREON2000A , environmental control device , decrease asthma severity , measure Composite Asthma Severity Index ( CASI ) , child mild moderate persistent allergic asthma twelve month period .</brief_summary>
	<brief_title>Investigate Effect CREON2000A Asthma Control Children With Mild Moderate Persistent Asthma</brief_title>
	<detailed_description>The pilot study ( Protocol # PA-01-052 ; Health Effects CREON2000 Asthmatic Children . IB ID # GI 1001 ) offer preliminary evidence CREON2000A system may beneficial asthma . This study follow-up , use child , age 6 17 mild moderate persistent asthma , subject study . Children usually treat few controller medication few confound co-morbidities make likely detect therapeutic benefit environmental intervention . The study involve 4 study site visit , 2 home visit , 7 phone call . Adjustment asthma therapy site clinician occur baseline ( Visit 1 ) follow-up office visit Visit 1 use modify algorithm base National Asthma Education Prevention Program Expert Panel Report 3 ( NAEPP EPR3 ) guideline . Enrollment 18 month . The study duration subject 12 month .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Inclusion criterion 1 . Males Females age 6.0 17.0 year . 2 . Subjects physician diagnosis mild moderate persistent asthma . 3 . FEV1 ≥ 60 % predict ≥ 12 % improvement bronchodilator therapy . 4 . Must evidence ; 1 ) serum specific IgE ( immunocap ) ≥ .35 2 ) positive skin prick test one common indoor allergen include standardized house dust mite , cat , dog , cockroach , mouse past . Exclusion criterion 1 . Current smoker 2 . Passive exposure environmental tobacco smoke home active fireplace source air particulate ( wood burn stove , kerosene heater ) home . 3 . Diagnosed physician chronic lung disease asthma . 4 . Upper low respiratory infection within four week prior enrollment . 5 . Known chronic illness ( besides asthma ) well controlled time screening ( Visit 1 ) . 6 . History life threaten asthma attack require cardiopulmonary support , intubation ventilatory support , hospitalization intensive care unit hospitalization asthma within 6 month precede study screening ( Visit 1 ) . 7 . Participation another investigational drug/device study within past 3 month ( include chart observational study )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>asthma environment</keyword>
</DOC>